Myosin Heavy Chain Myopathy and Immune-Mediated Muscle Disorders.

Area of Science:

• Veterinary Pathology
• Equine Medicine
• Immunology

Background:

• Inflammatory myopathies in horses often have infectious or immune-mediated origins.
• Myosin heavy chain myopathy, linked to a MYH1 gene variant, presents with immune-mediated myositis, calciphylaxis, or nonexertional rhabdomyolysis in Quarter Horse breeds.
• An infarctive form of purpura hemorrhagica affects various breeds, causing painful muscle swelling and tissue infarction, often triggered by Streptococcus equi equi but also other agents.

Purpose of the Study:

• To detail the diagnosis, pathophysiology, and treatment strategies for specific equine inflammatory myopathies.
• To elucidate the genetic basis and clinical presentations of myosin heavy chain myopathy.
• To identify common and potential inciting agents for infarctive purpura hemorrhagica.

Main Methods:

• Review of existing literature on equine inflammatory myopathies.
• Description of clinical signs, diagnostic approaches, and pathological findings.
• Discussion of genetic underpinnings and treatment protocols.

Main Results:

• Myosin heavy chain myopathy is associated with a specific MYH1 gene variant and exhibits distinct clinical syndromes.
• Purpura hemorrhagica can be triggered by various infectious agents, including Streptococcus equi equi, and leads to multi-tissue infarction.
• The article provides a comprehensive overview of these conditions.

Conclusions:

• Equine inflammatory myopathies are complex conditions requiring accurate diagnosis for effective management.
• Genetic factors and diverse infectious agents play significant roles in the etiology of these diseases.
• Further research into pathophysiology and treatment is warranted.